Anzeige
Mehr »
Login
Mittwoch, 19.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Doppeltes “STRONG BUY”! Jetzt bei EAM einsteigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 10.06.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
10.06.Sileon AB: David Larsson leaves his role as CEO for Sileon - Kent Hansson appointed acting CEO8Sileon AB's (publ) ("Sileon") Board of Directors has together with David Larsson agreed that he leaves his role as CEO that he has had since mid 2020. The Board has appointed Kent Hansson acting CEO...
► Artikel lesen
10.06.Ether Capital Corporation Announces Approval of the Proposed Transaction with Purpose, Voting Results of its 2024 Annual and Special Meeting of Shareholders and Business Update10TORONTO--(BUSINESS WIRE)--Ether Capital Corporation (Cboe CA: ETHC) ("Ether Capital" or the "Corporation") announced today that, at the annual and special meeting of the holders (the "Shareholders")...
► Artikel lesen
10.06.Technip Energies and Mitsubishi announce licensing of improved OXO alcohol technology 'OXO M-Process'400Technip Energies (PARIS:TE) and Mitsubishi Chemical Corporation (Mitsubishi Chemical), a member of the Mitsubishi Chemical Group, announced that they are licensing an improved OXO alcohol technology...
► Artikel lesen
10.06.FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Ongoing Disclosure Notice - Ordinary Shares-
10.06.SAS AB: Plan of reorganization in SAS AB's company reorganization announced51SAS AB (publ) (the "Company") announces the plan of reorganization in the Company's ongoing company reorganization proceeding (Sw. företagsrekonstruktion) in Sweden (the "Reorganization Plan"). The...
► Artikel lesen
10.06.GENFIT S.A.: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo for Primary Biliary Cholangitis115Ipsen's Iqirvo® (elafibranor) 80 mg tablets receives U.S. FDA accelerated approval as a first-in-class treatment for Primary Biliary Cholangitis (PBC)First-ever drug developed in-house by GENFIT to...
► Artikel lesen
10.06.Inception Growth Acquisition Limited Announces Extension of Business Combination Period and Additional Contribution to Trust Account to Extend Business Combination Period43New York, June 10, 2024 (GLOBE NEWSWIRE) -- Inception Growth Acquisition Limited (NASDAQ: IGTA, the "Company"), a publicly traded special purpose acquisition company, announced today that at its annual...
► Artikel lesen
10.06.Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to July 10, 202448Singapore, June 10, 2024 (GLOBE NEWSWIRE) -- Nova Vision Acquisition Corp. (NASDAQ: NOVV, the "Company"), a special purpose acquisition company, announced today that Nova Pulsar Holdings Limited,...
► Artikel lesen
10.06.VS Media Holdings Limited Announces 1-for-7 Share Combination64HONG KONG, June 10, 2024 (GLOBE NEWSWIRE) -- VS Media Holdings Limited (NASDAQ: VSME, the "Company"), a leader in managing a global network of digital creators, today announced that it plans to implement...
► Artikel lesen
10.06.Middlesex Water Company Names New Chief Financial Officer131ISELIN, N.J., June 10, 2024 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ: MSEX) has named Mohammed G. (Rally) Zerhouni as its new Senior Vice President, Chief Financial Officer and Treasurer...
► Artikel lesen
10.06.Calavo Growers, Inc. Announces Second Quarter 2024 Financial Results87SANTA PAULA, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global avocado industry leader and provider of convenient, ready-to-eat fresh food, today reported...
► Artikel lesen
10.06.Syntec Optics (NASDAQ: OPTX) Announces Dean Rudy as New Chief Financial Officer49ROCHESTER, NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Syntec Optics ("Syntec" or the "Company") (Nasdaq: OPTX) named Dean Rudy Chief Financial Officer, effective June 10, 2024. Mr. Rudy succeeds...
► Artikel lesen
10.06.byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination63New York, NY, June 10, 2024 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (NASDAQ: BYNO ("BYNO" or the "Company"), a special purpose acquisition company, announced today that the Company has...
► Artikel lesen
10.06.Array Technologies, Inc.: Array Technologies Announces Departure of Chief Financial Officer93ALBUQUERQUE, N.M., June 10, 2024 (GLOBE NEWSWIRE) -- Array Technologies (NASDAQ: ARRY) ("Array" or the "Company"), a leading provider of tracker solutions and services for utility-scale solar energy...
► Artikel lesen
10.06.TSS, Inc.: TSS Inc. (Total Site Solutions) Names Danny Chism as Chief Financial Officer122ROUND ROCK, Texas, June 10, 2024 (GLOBE NEWSWIRE) -- Total Site Solutions (OTC:TSSI), a leader in end-to-end integration technology solutions for data centers and modular services, today announced...
► Artikel lesen
10.06.Arcutis Biotherapeutics, Inc.: Arcutis Announces New Long-Term Data of Roflumilast Cream 0.15% for the Treatment of Mild to Moderate Atopic Dermatitis (AD) in Adults and Children Down to Age Six Presented at Revolutionizing Alopecia Areata, Vitiligo, and 67Investigational roflumilast cream 0.15% showed continued improvements in the signs and symptoms of AD, including itch, through 56 weeks of treatment66.2% of participants treated with once-daily roflumilast...
► Artikel lesen
10.06.2U, Inc.: 2U Announces 1-for-30 Reverse Stock Split187LANHAM, Md., June 10, 2024 /PRNewswire/ -- 2U, Inc. (Nasdaq: TWOU), a leading online education platform company, today announced that it will proceed with a 1-for-30 reverse stock split ("Reverse...
► Artikel lesen
10.06.Indivior PLC: Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder24Double-blind, placebo-controlled study aims to measure safety and efficacy of INDV-2000 over 3 months in participants with moderate to severe Opioid Use Disorder. INDV-2000 is an investigational non-opioid...
► Artikel lesen
10.06.Mind Technology, Inc. Reports Fiscal 2025 First Quarter Results209THE WOODLANDS, Texas, June 10, 2024 /PRNewswire/ -- MIND Technology, Inc. (NASDAQ: MIND) ("MIND" or the "Company") today announced financial results for its fiscal 2025 first quarter ended April...
► Artikel lesen
10.06.Vicarious Surgical Announces Reverse Stock Split93WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through...
► Artikel lesen
Seite:  Weiter >>